Changwei Dou

2.9k citations

46 papers · 1.8k indexed · h-index 22

Impact in

Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Hepatology top 5%
- Liver physiology and pathology

Papers in ⓘ

Molecular Biology 27
- Circular RNAs in diseases 6
- RNA modifications and cancer 5
Surgery 15
- Cholangiocarcinoma and Gallbladder Cancer Studies 10

Co-authors: Kangsheng Tu (20 shared papers)Zhikui Liu (17 shared papers)Yufeng Wang (10 shared papers)Xin Zheng (11 shared papers)Qingguang Liu (9 shared papers)Yuli Jia (9 shared papers)Wei Yang (8 shared papers)Bowen Yao (6 shared papers)
Journals: Surgical Endoscopy (3 papers)Oncotarget (3 papers)Cancer Letters (2 papers)Journal of Gastrointestinal Surgery (2 papers)Gastroenterology (2 papers)
Partner nations: China United States Taiwan

In The Last Decade

Changwei Dou

45 papers receiving 1.8k citations

Peers

Countries citing papers authored by Changwei Dou

Since Specialization

Citations

This map shows the geographic impact of Changwei Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changwei Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changwei Dou more than expected).

Fields of papers citing papers by Changwei Dou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changwei Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changwei Dou. The network helps show where Changwei Dou may publish in the future.

Co-authors

The 25 scholars most cited alongside Changwei Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Changwei Dou Line = papers co-authored together Changwei Dou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis Molecular Cancer ·Yufeng Wang, Zhikui Liu, Bowen Yao, Qing Li, Liang Wang, Cong Wang, Changwei Dou, Meng Xu, Qingguang Liu, Kangsheng Tu	2017	203
2	HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma Molecular Cancer ·Qiuran Xu, Jian‐Feng Tu, Changwei Dou, Jun Zhang, Liu Yang, Xin Liu, Kefeng Lei, Zhikui Liu, Yufeng Wang, Lijie Li, Hang-xing Bao, Jiahui Wang, Kangsheng Tu	2017	189
3	P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts Gastroenterology ·Changwei Dou, Zhikui Liu, Kangsheng Tu, Hongbin Zhang, Chen Chen, Usman Yaqoob, Yuanguo Wang, Jialing Wen, Jan van Deursen, Delphine Sicard, Daniel J. Tschumperlin, Hongzhi Zou, Wei‐Chien Huang, Raúl Urrutia, Vijay H. Shah, Ningling Kang	2018	175
4	Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma Theranostics ·Zhikui Liu, Yufeng Wang, Changwei Dou, Meng Xu, Liankang Sun, Liang Wang, Bowen Yao, Qing Li, Wei Yang, Kangsheng Tu, Qingguang Liu	2018	124
5	Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway Oncogene ·Changwei Dou, Zhenyu Zhou, Qiuran Xu, Zhikui Liu, Yuqun Zeng, Yufeng Wang, Qing Li, Liang Wang, Wei Yang, Qingguang Liu, Kangsheng Tu	2018	99
6	miR-187-3p inhibits the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by targeting S100A4 Cancer Letters ·Changwei Dou, Zhikui Liu, Meng Xu, Yuli Jia, Yufeng Wang, Qing Li, Wei Yang, Xin Zheng, Kangsheng Tu, Qingguang Liu	2016	91
7	p300 Acetyltransferase Is a Cytoplasm‐to‐Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β–Stimulated Hepatic Stellate Cells Hepatology ·Yuanguo Wang, Kangsheng Tu, Donglian Liu, Luyang Guo, Yun‐Ru Chen, Qing Li, Jessica L. Maiers, Zhikui Liu, Vijay H. Shah, Changwei Dou, Daniel J. Tschumperlin, Luke Voneschen, Rendong Yang, Ningling Kang	2019	77
8	Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling Cellular Physiology and Biochemistry ·Zhikui Liu, Kangsheng Tu, Yufeng Wang, Bowen Yao, Qing Li, Liang Wang, Changwei Dou, Qingguang Liu, Xin Zheng	2017	75
9	TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma Oncotarget ·Tao Song, Changwei Dou, Yuli Jia, Kangsheng Tu, Xin Zheng	2015	74
10	MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1 Oncotarget ·Changwei Dou, Yufeng Wang, Chao Li, Zhikui Liu, Yuli Jia, Qing Li, Wei Yang, Yingmin Yao, Qingguang Liu, Kangsheng Tu	2015	59
11	MicroRNA-130b Promotes Cell Aggressiveness by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Human Hepatocellular Carcinoma International Journal of Molecular Sciences ·Kangsheng Tu, Xin Zheng, Changwei Dou, Chao Li, Wei Yang, Yingmin Yao, Qingguang Liu	2014	54
12	SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production Journal of Experimental & Clinical Cancer Research ·Changwei Dou, Qiuran Xu, Jie Liu, Yufeng Wang, Zhenyu Zhou, Weifeng Yao, Kai Jiang, Jian Cheng, Chengwu Zhang, Kangsheng Tu	2019	52
13	MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7 Oncology Reports ·Wei Yang, Changwei Dou, Yufeng Wang, Yuli Jia, Chao Li, Xin Zheng, Kangsheng Tu	2015	51
14	CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma Oncotarget ·Xin Zheng, Tao Song, Changwei Dou, Yuli Jia, Qingguang Liu	2015	38
15	P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy Cell Death and Disease ·Yuli Jia, Meng Xu, Changwei Dou, Zhikui Liu, Yumo Xue, Bowen Yao, Lifeng Ding, Kangsheng Tu, Xin Zheng, Qingguang Liu	2016	37
16	PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1 Cancer Letters ·Qing Li, Zhikui Liu, Meng Xu, Yumo Xue, Bowen Yao, Changwei Dou, Yuli Jia, Yufeng Wang, Kangsheng Tu, Xin Zheng, Yingmin Yao	2016	37
17	Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis Biomedicine & Pharmacotherapy ·Qiuran Xu, Changwei Dou, Xin Liu, Yang Liu, Chao Ni, Jiahui Wang, Yang Guo, Wei Yang, Xiangmin Tong, Dongsheng Huang	2018	35
18	Total laparoscopic versus open radical resection for hilar cholangiocarcinoma Surgical Endoscopy ·Yuhua Zhang, Changwei Dou, Weiding Wu, Jie Liu, Liming Jin, Zhiming Hu, Cheng-Wu Zhang	2019	33
19	Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway Cell Death and Disease ·Changwei Dou, Liankang Sun, Liang Wang, Jian Cheng, Weiding Wu, Chengwu Zhang, Qiuran Xu, Kangsheng Tu, Jie Liu	2020	30
20	RIG-I suppresses the migration and invasion of hepatocellular carcinoma cells by regulating MMP9 International Journal of Oncology ·Zhikui Liu, Changwei Dou, Yuli Jia, Qing Li, Xin Zheng, Yingmin Yao, Qingguang Liu, Tao Song	2015	27

About Changwei Dou

Changwei Dou is a scholar working on Molecular Biology, Surgery, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers), Gallbladder and Bile Duct Disorders (5 papers), Gastric Cancer Management and Outcomes (5 papers), MicroRNA in disease regulation (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Cancer Research (852 citations), Hepatology (199 citations), Molecular Biology (1.2k citations), Oncology (334 citations) and Cell Biology (153 citations). Changwei Dou has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Kangsheng Tu, Zhikui Liu, Yufeng Wang, Xin Zheng, Qingguang Liu, Yuli Jia, Wei Yang, Bowen Yao, Meng Xu and Liang Wang. Their work appears in journals such as Surgical Endoscopy, Oncotarget, Cancer Letters, Journal of Gastrointestinal Surgery and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact